UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 289

Sortiert nach

Endocrine toxicities of immune checkpoint inhibitors

Nature reviews. Endocrinology, 2021-07, Vol.17 (7), p.389

2021

Volltextzugriff (PDF)

Increased Reporting of Immune Checkpoint Inhibitor-Associated Diabetes

Diabetes care, 2018-12, Vol.41 (12), p.e150-e151

2018

Volltextzugriff (PDF)

Contribution of Impaired Myocardial Insulin Signaling to Mitochondrial Dysfunction and Oxidative Stress in the Heart

Circulation (New York, N.Y.), 2009-03, Vol.119 (9), p.1272-1283

2009

Volltextzugriff (PDF)

Development of a standardized MRI protocol for pancreas assessment in humans

PloS one, 2021-08, Vol.16 (8), p.e0256029-e0256029

2021

Volltextzugriff (PDF)

Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding

Cardiovascular research, 2009-05, Vol.82 (2), p.351-360

2009

Volltextzugriff (PDF)

Approach to the Patient With Immune Checkpoint Inhibitor–Associated Endocrine Dysfunction

The journal of clinical endocrinology and metabolism, 2023-06, Vol.108 (6), p.1514-1525

2023

Volltextzugriff (PDF)

T cells specific for α-myosin drive immunotherapy-related myocarditis

Nature (London), 2022-11, Vol.611 (7937), p.818-826

2022

Volltextzugriff (PDF)

Pancreas Volume Declines During the First Year After Diagnosis of Type 1 Diabetes and Exhibits Altered Diffusion at Disease Onset

Diabetes care, 2019-02, Vol.42 (2), p.248-257

2019

Volltextzugriff (PDF)

Recurrence of Hypophysitis After Immune Checkpoint Inhibitor Rechallenge

The oncologist (Dayton, Ohio), 2022-12, Vol.27 (12), p.e967-e969

2022

Volltextzugriff (PDF)

Longitudinal MRI Shows Progressive Decline in Pancreas Size and Altered Pancreas Shape in Type 1 Diabetes

The journal of clinical endocrinology and metabolism, 2023-09, Vol.108 (10), p.2699-2707

2023

Volltextzugriff (PDF)

628-P: Accuracy of Continuous Glucose Monitoring (CGM) for Inpatient Diabetes Management

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

USE OF CONTINUOUS GLUCOSE MONITORING LEADS TO DIAGNOSIS OF HEMOGLOBIN C TRAIT IN A PATIENT WITH DISCREPANT HEMOGLOBIN A1C AND SELF-MONITORED BLOOD GLUCOSE

AACE clinical case reports, 2019-01, Vol.5 (1), p.e31-e34

2019

Volltextzugriff (PDF)

Decreased pancreatic acinar cell number in type 1 diabetes

Diabetologia, 2020-07, Vol.63 (7), p.1418-1423

2020

Volltextzugriff (PDF)

Accuracy of Continuous Glucose Monitors for Inpatient Diabetes Management

Journal of diabetes science and technology, 2023-09, Vol.17 (5), p.1252-1255

2023

Volltextzugriff (PDF)

206-OR: Insulin Gene Mutation in Family with Monogenic Diabetes Leads to Smaller Pancreas

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Mitochondrial energetics in the heart in obesity-related diabetes : Direct evidence for increased uncoupled respiration and activation of uncoupling proteins

Diabetes (New York, N.Y.), 2007-10, Vol.56 (10), p.2457-2466

2007

Volltextzugriff (PDF)

Insulin Deficiency From Insulin Gene Mutation Leads to Smaller Pancreas

Diabetes care, 2023-04, Vol.46 (4), p.773-776

2023

Volltextzugriff (PDF)

1374-P: In Type 2 Diabetes, the Exocrine Pancreas Has Greater Fibrosis, Fat, Metaplastic Changes, and Microangiopathy

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Longitudinal Assessment of Pancreas Volume by MRI Predicts Progression to Stage 3 Type 1 Diabetes

Diabetes care, 2024-03, Vol.47 (3), p.393

2024

Volltextzugriff (PDF)

Incretin response in immune checkpoint inhibitor-induced diabetes: an observational study

Diabetes & metabolism, 2021-09, Vol.47 (5), p.101212-101212, Article 101212

2021

Volltextzugriff (PDF)

2138-P: Pancreatic Exocrine Changes in Longstanding Type 1 Diabetes

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

35-OR: Multicenter MRI Assessment of the Pancreas in Type 1 Diabetes (MAP-T1D) Predicts Progression of Type 1 Diabetes

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

1894-P: Interruption of Glucagon Signaling Increases Pancreas Mass

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

1282-P: Assessment of Pancreas Volume and Shape Dynamics Longitudinally after T1D Diagnosis

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

1 – 25 von 289

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(259)
Mit Volltextzugriff
(264)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(289)
Japanisch
(36)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Endocrine toxicities of immune checkpoint inhibitors

Increased Reporting of Immune Checkpoint Inhibitor-Associated Diabetes

Contribution of Impaired Myocardial Insulin Signaling to Mitochondrial Dysfunction and Oxidative Stress in the Heart

Development of a standardized MRI protocol for pancreas assessment in humans

Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding

Approach to the Patient With Immune Checkpoint Inhibitor–Associated Endocrine Dysfunction

T cells specific for α-myosin drive immunotherapy-related myocarditis

Pancreas Volume Declines During the First Year After Diagnosis of Type 1 Diabetes and Exhibits Altered Diffusion at Disease Onset

Recurrence of Hypophysitis After Immune Checkpoint Inhibitor Rechallenge

Longitudinal MRI Shows Progressive Decline in Pancreas Size and Altered Pancreas Shape in Type 1 Diabetes

628-P: Accuracy of Continuous Glucose Monitoring (CGM) for Inpatient Diabetes Management

USE OF CONTINUOUS GLUCOSE MONITORING LEADS TO DIAGNOSIS OF HEMOGLOBIN C TRAIT IN A PATIENT WITH DISCREPANT HEMOGLOBIN A1C AND SELF-MONITORED BLOOD GLUCOSE

Decreased pancreatic acinar cell number in type 1 diabetes

Accuracy of Continuous Glucose Monitors for Inpatient Diabetes Management

206-OR: Insulin Gene Mutation in Family with Monogenic Diabetes Leads to Smaller Pancreas

Mitochondrial energetics in the heart in obesity-related diabetes : Direct evidence for increased uncoupled respiration and activation of uncoupling proteins

Insulin Deficiency From Insulin Gene Mutation Leads to Smaller Pancreas

1374-P: In Type 2 Diabetes, the Exocrine Pancreas Has Greater Fibrosis, Fat, Metaplastic Changes, and Microangiopathy

Longitudinal Assessment of Pancreas Volume by MRI Predicts Progression to Stage 3 Type 1 Diabetes

Genetic risk converges on regulatory networks mediating early type 2 diabetes

Incretin response in immune checkpoint inhibitor-induced diabetes: an observational study

2138-P: Pancreatic Exocrine Changes in Longstanding Type 1 Diabetes

35-OR: Multicenter MRI Assessment of the Pancreas in Type 1 Diabetes (MAP-T1D) Predicts Progression of Type 1 Diabetes

1894-P: Interruption of Glucagon Signaling Increases Pancreas Mass

1282-P: Assessment of Pancreas Volume and Shape Dynamics Longitudinally after T1D Diagnosis

Suchergebnisse filtern